oa SA Pharmaceutical Journal - Overview of the Single Exit Price Adjustment Process : forum

Volume 81, Issue 4
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



The pronouncement of the Regulations relating to the transparent pricing system for medicines and scheduled substances (Medicines and Related Substances Act 101 of 1965 as amended), introduced a Single Exit Price (SEP) for medicines in August 2004. The SEP is the price at which a manufacturer must sell to all pharmacies, irrespective of volume sold. The introduction of the single exit price ensured that no person shall supply any medicine according to a bonus system, rebate system or any other incentive scheme including sampling of medicines.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error